LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160,390,675 | -2.7% | 2,387,832 | -0.0% | 0.03% | 0.0% |
| Q2 2023 | $164,841,914 | +43.1% | 2,387,975 | -0.1% | 0.03% | +33.3% |
| Q1 2023 | $115,215,277 | -3.4% | 2,389,367 | -0.0% | 0.02% | -4.0% |
| Q4 2022 | $119,291,178 | +22.4% | 2,389,647 | +0.0% | 0.02% | +13.6% |
| Q3 2022 | $97,485,000 | -25.9% | 2,389,328 | -0.1% | 0.02% | -21.4% |
| Q2 2022 | $131,553,000 | +63.5% | 2,391,873 | +8.0% | 0.03% | +100.0% |
| Q1 2022 | $80,458,000 | +44.6% | 2,214,024 | +85.5% | 0.01% | +55.6% |
| Q4 2021 | $55,628,000 | -7.8% | 1,193,479 | 0.0% | 0.01% | -10.0% |
| Q3 2021 | $60,342,000 | +23.2% | 1,193,479 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $48,992,000 | +41.5% | 1,193,479 | 0.0% | 0.01% | +33.3% |
| Q1 2021 | $34,635,000 | +3.1% | 1,193,479 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $33,608,000 | +7.1% | 1,193,479 | +17.4% | 0.01% | -14.3% |
| Q3 2020 | $31,383,000 | +13.4% | 1,016,619 | +56.4% | 0.01% | 0.0% |
| Q2 2020 | $27,664,000 | – | 650,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |